CURRENT PHARMACEUTICAL DESIGN

Scope & Guideline

Pioneering Insights in Pharmacology and Drug Development

Introduction

Welcome to your portal for understanding CURRENT PHARMACEUTICAL DESIGN, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1381-6128
PublisherBENTHAM SCIENCE PUBL LTD
Support Open AccessNo
CountryUnited Arab Emirates
TypeJournal
Convergefrom 1995 to 2024
AbbreviationCURR PHARM DESIGN / Curr. Pharm. Design
Frequency46 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressEXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES

Aims and Scopes

CURRENT PHARMACEUTICAL DESIGN is dedicated to advancing the field of pharmaceutical sciences through innovative research and development. The journal encompasses a wide range of topics relevant to drug design, formulation, and delivery, emphasizing the integration of modern technologies and methodologies.
  1. Drug Delivery Systems and Technologies:
    The journal focuses on novel drug delivery systems, including nanotechnology, liposomes, and microfluidics, exploring their application in enhancing bioavailability and therapeutic efficacy.
  2. Pharmacological Mechanisms and Therapeutics:
    Research on the pharmacological mechanisms of various compounds, including natural products and synthetic drugs, is a core focus, highlighting their therapeutic potentials and applications in diseases.
  3. Integrative Approaches in Drug Design:
    CURRENT PHARMACEUTICAL DESIGN promotes integrative methodologies combining network pharmacology, computational modeling, and bioinformatics to uncover mechanisms of action and identify potential drug targets.
  4. Emerging Therapeutics and Biologics:
    The journal emphasizes the development of new therapeutic modalities, including biologics, gene therapies, and advanced drug formulations, addressing unmet medical needs.
  5. Natural Products and Traditional Medicine:
    Research exploring the pharmacological effects of natural products and traditional medicinal practices is highlighted, showcasing their potential in modern therapeutic applications.
  6. Clinical and Translational Research:
    CURRENT PHARMACEUTICAL DESIGN also covers clinical studies and translational research, focusing on the application of laboratory findings to clinical practice for better patient outcomes.
CURRENT PHARMACEUTICAL DESIGN is witnessing significant trends and emerging themes that reflect the evolving landscape of pharmaceutical research. These themes highlight the journal's commitment to addressing contemporary challenges in drug design and delivery.
  1. Artificial Intelligence and Machine Learning in Drug Discovery:
    Recent publications have increasingly focused on the application of AI and machine learning techniques for drug discovery, optimizing drug design processes and identifying new therapeutic targets.
  2. Nanotechnology in Therapeutics:
    There is a growing emphasis on the use of nanotechnology for drug delivery systems, highlighting their potential to improve targeting, bioavailability, and patient compliance.
  3. Network Pharmacology and Systems Biology:
    Research integrating network pharmacology and systems biology approaches has gained momentum, facilitating a comprehensive understanding of complex interactions in drug action.
  4. Personalized Medicine and Pharmacogenomics:
    The journal is increasingly publishing studies related to personalized medicine, emphasizing the importance of pharmacogenomics in tailoring therapies to individual patient profiles.
  5. Natural Products in Drug Development:
    Emerging research highlights the role of natural products and their derivatives in drug development, showcasing their potential as sources of novel therapeutics.
  6. Therapeutic Applications of Microbiome Research:
    There is a rising interest in the therapeutic implications of microbiome research, particularly its influence on drug metabolism and disease treatment.

Declining or Waning

While CURRENT PHARMACEUTICAL DESIGN has a broad range of active research areas, some themes have shown a decline in frequency and relevance in recent publications. This may indicate a shift in research focus or advancements in other areas.
  1. Conventional Drug Formulation Techniques:
    Research on traditional drug formulation methods has decreased as more innovative and technologically advanced methods gain traction, such as nanotechnology and smart delivery systems.
  2. Single-target Drug Discovery:
    There is a noticeable decline in studies focusing solely on single-target drug discovery, with a shift towards multi-target and systems pharmacology approaches.
  3. Basic Pharmacokinetics Studies:
    Basic pharmacokinetic studies have become less prevalent as the field moves towards more complex modeling and simulation techniques that provide deeper insights into drug behavior.
  4. Focus on Synthetic Drugs:
    Research on synthetic drugs alone has waned, with a growing emphasis on biologics, natural products, and hybrid formulations that incorporate both synthetic and natural elements.
  5. Traditional Medicinal Practices without Scientific Validation:
    The journal has seen a reduction in articles solely discussing traditional medicinal practices without robust scientific evidence, reflecting a shift towards evidence-based approaches.

Similar Journals

Pharmaceutical Sciences

Pioneering research at the intersection of science and health.
Publisher: TABRIZ UNIV MEDICAL SCIENCES, FAC PHARMACYISSN: 1735-403XFrequency: 4 issues/year

Pharmaceutical Sciences, an esteemed journal published by Tabriz University of Medical Sciences, Faculty of Pharmacy, serves as a crucial platform for the dissemination of pioneering research in the fields of pharmaceutical science, pharmacology, and toxicology. With an impact factor reflective of its substantial contribution to the scientific community, this open access journal has been accessible since 2012, ensuring that researchers, professionals, and students worldwide can engage with its rich content. Located in Iran, it has continually evolved, covering research from 2009 to 2024, and boasts impressive rankings in multiple Scopus categories, including Q3 in Pharmaceutical Science and Q2 in Pharmacology, Toxicology and Pharmaceutics. By bridging gaps between scientific inquiry and practical applications, Pharmaceutical Sciences is dedicated to advancing pharmaceutical knowledge and promoting innovative practices that address significant health challenges.

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Transforming Ideas into Effective Therapies
Publisher: TAYLOR & FRANCIS LTDISSN: 0363-9045Frequency: 12 issues/year

Drug Development and Industrial Pharmacy is a prestigious journal published by Taylor & Francis Ltd, focusing on the critical field of pharmaceutical sciences. With an ISSN of 0363-9045 and an E-ISSN of 1520-5762, the journal has been an essential resource for researchers and professionals since its inception in 1974. It occupies a crucial niche within Drug Discovery, Organic Chemistry, and Pharmaceutical Science, currently ranked in the second and third quartiles, reflecting its solid contribution to the field. The journal encompasses a wide array of topics, including drug development processes, formulation, and industrial manufacturing alongside cutting-edge research in pharmacology and toxicology. With a commendable Scopus ranking demonstrating high relevance—ranked #44 in Pharmaceutical Science—it serves as a vital forum for academia and industry to share innovative findings and methodologies. While it does not offer open access, the journal remains an invaluable resource for those seeking to advance their knowledge and enhance their research in pharmaceutical development.

CURRENT DRUG TARGETS

Elevating Drug Discovery to New Heights
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1389-4501Frequency: 16 issues/year

CURRENT DRUG TARGETS is a leading peer-reviewed journal dedicated to advancements in the fields of Clinical Biochemistry, Drug Discovery, Molecular Medicine, and Pharmacology. Published by Bentham Science Publishers Ltd, this esteemed journal has solidified its position in the academic community with a 2023 Q2 ranking in several categories, highlighting its influence and relevance in drug research and development. With an ISSN of 1389-4501 and E-ISSN 1873-5592, CURRENT DRUG TARGETS facilitates the dissemination of high-quality articles that explore novel therapeutic strategies and drug design principles. Catered to researchers, professionals, and students, the journal has a commitment to advancing knowledge while addressing contemporary challenges in pharmacological sciences. As it converges from 2000 to 2024, CURRENT DRUG TARGETS remains a vital resource in understanding the complexities of drug action and interaction, making it indispensable for anyone pursuing cutting-edge research in related disciplines.

Advances in Pharmacological and Pharmaceutical Sciences

Unlocking the Future of Therapeutic Practices.
Publisher: HINDAWI LTDISSN: 2633-4682Frequency: 1 issue/year

Advances in Pharmacological and Pharmaceutical Sciences is a premier open-access journal published by Hindawi Ltd. based in the United Kingdom. Established in 2020, the journal swiftly garnered attention for its commitment to disseminating high-quality research in the realms of pharmacology, toxicology, and pharmaceutical sciences. It holds a commendable impact with notable quartile rankings, including Q2 in both Organic Chemistry and Pharmacology, indicating its importance within these disciplines. By embracing an open-access model, the journal ensures that research findings are widely available, promoting increased visibility and collaboration among researchers, professionals, and students globally. With an ongoing convergence of insights projected through 2024, Advances in Pharmacological and Pharmaceutical Sciences aims to address critical issues and advancements in drug development and therapeutic practices, making it an invaluable resource for those at the forefront of scientific inquiry in pharmacology and related fields.

International Journal of Pharmaceutical Investigation

Empowering Researchers with Insightful Pharmaceutical Knowledge
Publisher: INPHARM ASSOC, PHCOG NETISSN: 2230-973XFrequency: 4 issues/year

International Journal of Pharmaceutical Investigation, published by INPHARM ASSOC, PHCOG NET, is a premier platform dedicated to advancing the field of pharmaceutical sciences. With the ISSN 2230-973X and E-ISSN 2230-9713, this journal serves as a vital resource for researchers, professionals, and students focused on drug development, formulation, and efficacy. By fostering a rich discourse on innovative pharmaceutical practices and research breakthroughs, the journal plays a critical role in enhancing global health outcomes through groundbreaking scholarly work. The absence of open access allows for selective dissemination of high-quality content, promoting rigorous peer-review processes that uphold academic integrity. Featuring articles that span a diverse range of topics within pharmaceutical sciences, the International Journal of Pharmaceutical Investigation is committed to supporting the ongoing evolution of this dynamic field, making it an essential read for anyone engaged in pharmaceutical research and development.

PHARMACIA

Championing cutting-edge discoveries in pharmacology and toxicology.
Publisher: PENSOFT PUBLISHERSISSN: 0428-0296Frequency: 4 issues/year

PHARMACIA is a distinguished open-access journal, published by PENSOFT PUBLISHERS, that has been a pivotal platform for advancing the field of pharmaceutical sciences since 2007. This journal, with ISSN 0428-0296 and E-ISSN 2603-557X, is based in Bulgaria and continues to publish high-quality research and reviews relevant to pharmacy, pharmacology, and toxicology. Recognized in the Q3 category for Pharmaceutical Sciences and Pharmacology (medical), as well as Q2 in Pharmacy according to the latest rankings, PHARMACIA is celebrated for its commitment to fostering knowledge dissemination and innovation in drug development, therapeutic approaches, and pharmacological research. With a Scopus rank of #17 in Pharmacy and recognition in various health professions, the journal attracts contributions from researchers, professionals, and students seeking to impact the pharmaceutical landscape. Its convenient open-access format ensures that articles are readily available to a global audience, encouraging collaboration and advancement in the life sciences.

Journal of Pharmaceutical Innovation

Shaping the Future of Drug Development
Publisher: SPRINGERISSN: 1872-5120Frequency: 4 issues/year

The Journal of Pharmaceutical Innovation, published by SPRINGER, serves as a vital resource in the fields of Pharmaceutical Science and Drug Discovery. With an ISSN of 1872-5120 and an E-ISSN of 1939-8042, this journal has been disseminating significant research findings since its inception in 2006. It is recognized for its rigorous peer-review process, maintaining a respectable ranking of Q2 in Pharmaceutical Science and Q3 in Drug Discovery as of 2023. Researchers and practitioners benefit from the journal's diverse scope, which encompasses innovative methodologies and advancements in pharmaceuticals, thereby fostering knowledge and collaboration within the scientific community. Although it does not offer Open Access options, the journal is accessible through institutional subscriptions and libraries, ensuring that critical insights in drug development and pharmacology reach a broad audience. The geographical presence of the journal in the United States underscores its influence in shaping the pharmaceutical landscape on a global scale.

Drug Delivery and Translational Research

Exploring New Frontiers in Drug Delivery and Pharmacokinetics.
Publisher: SPRINGER HEIDELBERGISSN: 2190-393XFrequency: 12 issues/year

Drug Delivery and Translational Research (ISSN: 2190-393X | E-ISSN: 2190-3948), published by Springer Heidelberg, stands at the forefront of the Pharmaceutical Sciences discipline, boasting a prestigious impact factor as evidenced by its Q1 category ranking in 2023. This esteemed journal is dedicated to the vital intersection of drug delivery systems and translational research, aiming to bridge the gap between laboratory findings and clinical applications. It features groundbreaking studies that enhance our understanding of drug pharmacokinetics, formulations, and patient-centered research, making it indispensable for researchers, professionals, and students striving to innovate and excel in the field. While the journal operates under a subscription model, its commitment to disseminating high-quality research is reflected in its Scopus rank, placing it in the top 6% of its category (Rank #11/183, 94th percentile). Since its inception in 2011, it has garnered significant attention, promoting advances in pharmacology, toxicology, and pharmaceutics, and continues to be a platform for vital discourse and discovery.

FARMACIA

Unveiling Insights in Pharmacotherapy and Beyond.
Publisher: SOC STIINTE FARMACEUTICE ROMANIAISSN: 0014-8237Frequency: 6 issues/year

FARMACIA is a renowned academic journal published by the SOC STIINTE FARMACEUTICE ROMANIA, specializing in the field of pharmacology, toxicology, and pharmaceutics. With a rich history dating back to its initial publication years of 1945 to 1946, and ongoing contributions since 2008, the journal has established itself as a significant platform for disseminating cutting-edge research in the pharmaceutical sciences. Indexed in Scopus, it holds a commendable Q2 ranking in the Pharmacology, Toxicology and Pharmaceutics category, reflecting its importance in the field. The journal aims to foster knowledge sharing and innovation among researchers, professionals, and students alike, making it an essential resource for advancing pharmaceutical research. Although it does not currently offer Open Access, the content is accessible to a broad academic audience, ensuring valuable insights into current trends and discoveries in pharmacotherapy and drug development. For those seeking a deeper understanding of the evolving landscape of pharmaceutical sciences, FARMACIA provides a critical lens through which to explore and engage with the latest scientific advancements.

Journal of Pharmacy & Pharmacognosy Research

Elevating Standards in Pharmaceutical Science
Publisher: JOURNAL PHARMACY & PHARMACOGNOSY RESEARCH-JPPRESISSN: 0719-4250Frequency: 6 issues/year

Journal of Pharmacy & Pharmacognosy Research, published by JOURNAL PHARMACY & PHARMACOGNOSY RESEARCH-JPPRES, is a prominent open-access journal established in 2013, headquartered in Antofagasta, Chile. With a focus on the fields of Complementary and Alternative Medicine, Drug Discovery, Pharmaceutical Science, Pharmacology, and Pharmacy, this journal is recognized for its commitment to advancing research and disseminating knowledge within these important areas. With a current impact factor that reflects its academic rigor and relevance, the journal has achieved substantial recognition, evident by its Q2 and Q3 quartile rankings in multiple categories, indicating its growing influence on the scientific community. The Scopus rankings further highlight its standing in pharmacy and pharmacological disciplines, providing a valuable platform for researchers, professionals, and students to share their findings and insights. With its open access model, the journal ensures that high-quality research is available to a global audience, paving the way for collaborative advancements in pharmaceutical sciences.